01 1Bausch Health, Canada Inc.
02 2GlaxoSmithKline Inc.
01 12130341
02 12142530
03 12723029
01 1CLINDAMYCIN PHOSPHATE | ADAPALENE | BENZOYL PEROXIDE
02 2Clindamycin Phosphate | Benzoyl Peroxide
01 1GEL
02 2Gel
01 12013-01-15
02 12015-02-14
03 12029-06-03
Patent Expiration Date : 2029-06-03
Date Granted : 2016-07-19
Clindamycin Phosphate, Adapalene, Benzoyl Peroxide
Brand Name : CABTREO
Patent Number : 2723029
Filing Date : 2009-06-03
Strength per Unit : 1.2 % w / w, 0.15 % w / w and 3.1 % w / w
Dosage Form : GEL
Human Or VET : Human
Route of Administration : TOPICAL
Patent Expiration Date : 2029-06-03
Date Granted : 2016-07-19
Patent Expiration Date : 2015-02-14
Date Granted : 2006-12-05
Clindamycin Phosphate, Benzoyl Peroxide
Brand Name : CLINDOXYL GEL
Patent Number : 2142530
Filing Date : 1995-02-14
Strength per Unit : 1% clindamycin as phsphate & 5% benzoyl perxide
Dosage Form : Gel
Human Or VET : Human
Route of Administration : Topical
Patent Expiration Date : 2015-02-14
Date Granted : 2006-12-05
Patent Expiration Date : 2013-01-15
Date Granted : 1997-10-14
Clindamycin Phosphate, Benzoyl Peroxide
Brand Name : CLINDOXYL
Patent Number : 2130341
Filing Date : 1993-01-15
Strength per Unit : 1% / 3%
Dosage Form : Gel
Human Or VET : Human
Route of Administration : Topical
Patent Expiration Date : 2013-01-15
Date Granted : 1997-10-14
